Pharma as a sector has been witnessing a mixed newflow and now that not so good part of that “mixed” is also turning better. First the domestic companies, sellect domestic pharma companies which have been pushing for backward integration have seen some improvement in their margins as supply chain disruption are also behind them.
Read more on economictimes.indiatimes.com